Catalogo dei prodotti della ricerca

ZINGONI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.878
EU - Europa 1.646
AS - Asia 771
AF - Africa 38
SA - Sud America 31
Totale 6.364
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.853
IT - Italia 816
SG - Singapore 291
DE - Germania 239
CN - Cina 226
IN - India 154
UA - Ucraina 86
FR - Francia 82
NL - Olanda 80
FI - Finlandia 78
SE - Svezia 74
GB - Regno Unito 45
RU - Federazione Russa 36
BG - Bulgaria 34
TG - Togo 31
ID - Indonesia 27
KR - Corea 26
CA - Canada 16
IR - Iran 16
AR - Argentina 15
AT - Austria 15
IE - Irlanda 15
BE - Belgio 11
CH - Svizzera 8
ES - Italia 8
RO - Romania 8
TR - Turchia 8
BZ - Belize 7
HK - Hong Kong 7
BR - Brasile 6
JP - Giappone 6
CL - Cile 4
DK - Danimarca 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
IL - Israele 3
NG - Nigeria 3
PE - Perù 3
TW - Taiwan 3
ZA - Sudafrica 3
AL - Albania 2
GR - Grecia 2
BA - Bosnia-Erzegovina 1
MU - Mauritius 1
MX - Messico 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
TH - Thailandia 1
Totale 6.364
Salva come PNG Salva come JPEG
Città #
Fairfield 585
Ashburn 392
Rome 375
Woodbridge 266
Houston 248
Seattle 237
Chandler 233
Ann Arbor 223
Singapore 209
Wilmington 198
Cambridge 169
Santa Clara 165
Princeton 90
Dearborn 79
Beijing 74
Paris 70
Fasano 64
San Paolo di Civitate 63
Plano 62
Lawrence 56
Boston 38
Millbury 36
San Diego 34
Sofia 34
Lomé 31
Jacksonville 30
Andover 27
Helsinki 27
Jakarta 27
Falls Church 21
New York 21
San Jose 21
Boardman 18
Milan 18
Federal 14
Phoenix 14
Tivoli 14
Fremont 13
Washington 13
Dublin 12
Hefei 12
Vienna 11
Brussels 10
Norwalk 10
Pune 10
Amsterdam 9
Des Moines 8
Belize City 7
Hangzhou 7
Key Biscayne 7
Madrid 7
Mannheim 7
Tehran 7
Toronto 7
Falkenstein 6
London 6
Palermo 6
Parma 6
Zanjan 6
Berlin 5
Bologna 5
Bremen 5
Dongjak-gu 5
Frankfurt am Main 5
Grafing 5
Kunming 5
Nanjing 5
Naples 5
Nettuno 5
Redwood City 5
Sacramento 5
Southend 5
Ancona 4
Artena 4
Atlanta 4
Bern 4
Brescia 4
Bühl 4
Camerino 4
Castel Gandolfo 4
Dallas 4
Fenile 4
Istanbul 4
Monterotondo 4
Santiago 4
Seongbuk-gu 4
Bellevue 3
Buffalo 3
Chiba 3
Den Helder 3
Duarte 3
Hebei 3
Karlsruhe 3
Leawood 3
Los Angeles 3
Oakville 3
Ottawa 3
Pohang 3
Pontelandolfo 3
Rimini 3
Totale 4.633
Salva come PNG Salva come JPEG
Nome #
Immune complexes exposed on mast cell-derived nanovesicles amplify allergic inflammation 195
Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70/TLR2/NF-kB axis 162
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells 156
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells. role of cMYC-IRF4-miR-125b interplay 155
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma 143
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA. Dual role in cancer immunosurveillance 134
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation 131
Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms 123
Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice 122
Interplay of protein corona and immune cells controls blood residency of liposomes 120
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in multiple myeloma. modulation by bromodomain and Extra-Terminal (BET) protein inhibitors 119
Drug-induced senescent Multiple Myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL-15 trans-presentation 117
Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells. 105
Targeting NKG2D and NKp30 ligands shedding to improve NK cell–based immunotherapy 104
Bone marrow stromal cell-derived IL-8 upregulates PVR expression on multiple myeloma cells via NF-kB transcription factor 101
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression 99
Cancer extracellular vesicles as novel regulators of NK cell response 99
NKG2D and its ligands: one for all, all for one 97
Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment. 96
c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells. 94
High expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma 94
DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction 93
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis 92
Translating the anti-myeloma activity of Natural Killer cells into clinical application 92
Cancer Exosomes as Conveyors of Stress-Induced Molecules: New Players in the Modulation of NK Cell Response. 92
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients 91
Key role of the CD56lowCD16low Natural Killer cell subset in the recognition and killing of Multiple Myeloma cells 89
MICA-129 dimorphism and soluble MICA are associated with the progression of multiple myeloma 87
null 87
The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells 87
Recognition of a carbohydrate xenoepitope by human NKRP1A (CD161) 84
Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. 81
Isolation and chromosomal localization of GPR31, a human gene encoding a putative G protein-coupled receptor 81
Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8(+) T cells 80
ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype 75
Natural killer (NK) cells from killers to regulators: Distinct features between peripheral blood and decidual NK cells 74
Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells 73
Natural killer cell response to chemotherapy-stressed cancer cells: Role in tumor immunosurveillance. 73
Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7 71
An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation 70
High-efficient lentiviral vector-mediated gene transfer into primary human NK cells 69
Modulation of T Cell-Mediated Immune Responses by Natural Killer Cells 68
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation 68
Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3 67
NK cell regulation of T cell-mediated responses 66
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma 66
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity 66
Post-translational mechanisms regulating NK cell activating receptors and their ligands in cancer: Potential targets for therapeutic intervention 66
Opsonin-deficient nucleoproteic corona endows unPEGylated liposomes with stealth properties in vivo 66
Human Leukocyte Antigen E Contributes to Protect Tumor Cells from Lysis by Natural Killer Cells 65
Hepatitis C virus direct-acting antivirals therapy impacts on extracellular vesicles microRNAs content and on their immunomodulating properties 65
NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2 64
Molecular cloning and expression of cDNA encoding the rat UDP-N-Acetylglucosamine:-6-D Mannoside ?-1,2-N-Acetylglucosaminyltransferase II 64
The activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma (MM) cells. 63
null 62
NKG2D ligand shedding in response to stress: role of ADAM10 60
CD94/NKG2-A inibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. 59
Natural killer cells as regulators of T cell-mediated immune responses. 58
Doxorubicin–Mediated miR–433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR–Independent Manner 54
CD69-triggered ERK activation and functions are negatively regulated by CD94/NKG2A inhibitory receptor. 53
NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: Role in the NK cell-mediated negative regulation of T cell responses 52
NKG2D down-modulation on human NK cells is followed by DNAM-1 hypo-responsivenss 51
Samhd1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 50
NKG2D engagement on human NK cells leads to DNAM‐1 hypo‐responsiveness through different converging mechanisms 49
The senescence journey in cancer immunoediting 48
The chemokine receptor CCR8 is preferentially expressed in Th2 but not in Th1 cells 48
IL-3 induces differentiation and growth of thymocytes and splenic T and B lymphocytes in irradiated mice 45
Large−scale profiling of extracellular vesicles identified miR−625−5p as a novel biomarker of immunotherapy response in advanced non−small−cell lung cancer patients 45
The possible role of sex as an important factor in development and administration of lipid nanomedicine-based COVID-19 vaccine 44
null 44
When damage prevents cancer: the activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma cells 44
In vitro and ex vivo nano-enabled immunomodulation by the protein corona 42
Differential shedding of the MICA and the MICB NKG2D ligands from multiple myeloma cells in response to genotoxic stress 41
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer 41
Down-Regulation of the Activating Receptor NKG2D by its Ligands Expressed on T Lymphocytes: A New Mechanism to Limit CD8+ T Cell Immune Responses. 39
Down-regulation of the NKG2D receptor is differentially controlled by MICA and ULBP2 ligands 38
CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma 37
Regulation of MICB shedding from multiple myeloma cells in response to genotoxic stress. 37
Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues 33
The CD94/NKG2A killer inhibitory receptor inhibits CD69 receptor-induced mast cell degranulation 31
Molecular cloning and expression of cDNA encoding RAT- UDP- N-Acetylglucosamyniltransferase II 29
Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells 28
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing 27
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells 26
Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery 25
Human NK cells: a new candidate for IL-17 production 23
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells 22
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition 22
Optimizing transfection efficiency in CAR-T cell manufacturing through multiple administrations of lipid-based nanoparticles 21
null 21
PIGR-enriched circulating vesicles contributes to hepatocellular carcinoma aggressiveness 20
null 19
Impact of the protein corona on nanomaterial immune response and targeting ability 15
MICA and ULBP2 differentially regulate NKG2D cell surface expression 14
Rescue SLAMF7 activity in exhausted natural killer cells: Novel challenges in the immunotherapy of multiple myeloma 12
null 12
Senescent cells: Living or dying is a matter of NK cells 11
Tuning the Orchestra: HCMV vs. Innate Immunity 11
Small extracellular vesicle-delivered microRNAs promote IFN-alpha secretion by plasmacytoid DCs via TLR7 11
Women in NK and innate lymphoid cell biology 6
Totale 6.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.044 0 0 0 0 121 204 182 144 160 128 63 42
2020/2021720 52 62 24 24 20 39 81 26 42 217 60 73
2021/2022861 5 45 112 29 105 27 29 88 72 75 147 127
2022/20231.058 195 273 45 62 110 102 12 72 70 6 50 61
2023/2024847 40 92 44 66 92 155 43 46 26 112 66 65
2024/2025630 56 42 80 193 259 0 0 0 0 0 0 0
Totale 6.641